A cost-utility analysis of adding SGLT2 inhibitors for the management of type 2 diabetes with chronic kidney disease in Thailand by Natthakan Chitpim, Pattara Leelahavarong, Juthamas Prawjaeng, Sakditat Ittiphisit, Varalak Srinonprasert, Tanawan Kongmalai

Get full text

Impact of Frailty on Healthcare Utilization in Older Patients Admitted to Medical Wards: A Study from a Large Medical School in a Middle-income Setting by Patumporn Suraarunsumrit, Pacha Sinthornkasem, Ponnapa Petchthai, Supawadee Sainimnuan, Rinrada Preedachitkul, Varalak Srinonprasert

Get full text

Reliability and Validity of the Thai Version of the PAINAD Scale: An Extended Application of Pain Assessment in the Moderately Severe Stage of Dementia by Natthapapath Boonsawat, Patumporn Suraarunsumrit, Sutisa Pitiyarn, Napaporn Pengsorn, Varalak Srinonprasert, Sahatsa Mandee, Titima Wongviriyawong

Get full text

Health Survey of Monks Residing in Urban Areas: The Bangkok Noi Model by Wasumadee Ko-amornsup, Arunotai Siriussawakul, Kanuch Aosangdeeku, Rinrada Preedachitkul, Varalak Srinonprasert, Pawit Somnuke, Weerasak Muangpaisan, Ponnapa Petchthai, Naris Kitnarong

Get full text

Botulinum toxin type A for the treatment of patients with post-stroke spasticity in Thailand: cost-utility and budget impact analysis by Phorntida Hadnorntun, Pattara Leelahavarong, Tanawan Kongmalai, Varalak Srinonprasert, Juthamas Prawjaeng, Phakamas Tanvijit, Chuenchom Chueluecha, Nawarat Jintakul, Tipyarat Saringcarinkul, Witsanu Kumthornthip

Get full text

Can SGLT-2 inhibitors improve cardiovascular outcomes and ensure safety for patients with type 2 diabetes and heart failure in Thailand? A real-world multicentre retrospective coho... by Ammarin Thakkinstian, Amarit Tansawet, Oraluck Pattanaprateep, Tanawan Kongmalai, Panu Looareesuwan, Hataikarn Nimitphong, Cholatid Ratanatharathorn, Porntep Amornritvanich, Burin Boonwatcharapai, Anon Khunakorncharatphong, Varalak Srinonprasert

Get full text